Forty51 Ventures

Allegria Therapeutics is a biotechnology company dedicated to enhancing the treatment landscape for allergy and inflammatory diseases. The firm specializes in research and development centered on mast cells, which play a crucial role in mediating these conditions. By focusing on this area, Allegria Therapeutics aims to address the growing global burden of such diseases, ultimately enabling individuals to achieve a healthier lifestyle.

Mysthera Therapeutics is a preclinical-stage biotechnology company focused on developing innovative oral therapeutics for autoimmune diseases. The company aims to reshape the treatment landscape by addressing conditions such as glomerulonephritis, rheumatoid arthritis, and inflammatory bowel disease. Mysthera Therapeutics utilizes a unique approach that involves the inhibition of PIM kinases, which allows for the selective modulation of immune cell function across multiple lineages involved in complex autoimmune disorders. By doing so, the company seeks to provide effective treatments for significant unmet medical needs in this area.

Mosanna Therapeutics is a biotechnology company based in Basel that focuses on improving patient outcomes and quality of life for individuals with high unmet medical needs. The company employs a precision medicine approach, specializing in the development of medicinal nasal sprays. Mosanna carefully selects innovative medicines for further development and collaborates with leading contract research organizations to ensure expertise in specialized fields. This strategy enables hospitals and doctors to effectively treat patients suffering from various diseases.

Mosanna Therapeutics is a biotechnology company based in Basel that focuses on improving patient outcomes and quality of life for individuals with high unmet medical needs. The company employs a precision medicine approach, specializing in the development of medicinal nasal sprays. Mosanna carefully selects innovative medicines for further development and collaborates with leading contract research organizations to ensure expertise in specialized fields. This strategy enables hospitals and doctors to effectively treat patients suffering from various diseases.